| 1 |
34255218 | Hsa_circ_0006404 and hsa_circ_0000735 Regulated Ovarian Cancer Response to Docetaxel Treatment via Regulating p-GP Expression. | 2022 Feb |
3 |
| 2 |
33691261 | Therapeutic strategies to overcome taxane resistance in cancer. | 2021 Mar |
1 |
| 3 |
32001291 | Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance. | 2020 Mar 30 |
2 |
| 4 |
32174789 | Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways. | 2020 |
1 |
| 5 |
30637776 | Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India. | 2019 Apr |
1 |
| 6 |
30897775 | LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats. | 2019 Mar 20 |
2 |
| 7 |
31267877 | Evaluation of the Synergism Mechanism of Tamoxifen and Docetaxel by Nanoparticles. | 2019 |
1 |
| 8 |
29675746 | Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein. | 2018 Jun |
2 |
| 9 |
27988472 | Co-delivery of docetaxel and verapamil by reduction-sensitive PEG-PLGA-SS-DTX conjugate micelles to reverse the multi-drug resistance of breast cancer. | 2017 Mar 1 |
4 |
| 10 |
28915246 | Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance. | 2017 |
1 |
| 11 |
27213719 | Design, Synthesis, and Preclinical Evaluation of 4-Substituted-5-methyl-furo[2,3-d]pyrimidines as Microtubule Targeting Agents That Are Effective against Multidrug Resistant Cancer Cells. | 2016 Jun 23 |
1 |
| 12 |
26372815 | Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer. | 2015 Dec |
3 |
| 13 |
32262303 | Docetaxel-loaded PEO-PPO-PCL/TPGS mixed micelles for overcoming multidrug resistance and enhancing antitumor efficacy. | 2015 May 28 |
1 |
| 14 |
22439872 | Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes. | 2012 |
1 |
| 15 |
23251413 | Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. | 2012 |
2 |
| 16 |
19499189 | Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. | 2010 Aug |
1 |
| 17 |
20416158 | [Docetaxel induces apoptosis and influences the expression of P-gp, BCL-2 and BAX protein in HL-60/ADR cells]. | 2010 Apr |
1 |
| 18 |
10914699 | Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. | 2000 Jul |
3 |
| 19 |
11102737 | Modulation of oral bioavailability of anticancer drugs: from mouse to man. | 2000 Dec |
1 |